Learn about options for managing the inflammatory bowel disease ulcerative colitis, including prescription medications, ...

Increasing incidences and prevalence of ulcerative colitis, demand for drugs has been increased across the globe. The North America region emerged as the largest market for the ulcerative colitis drug ...

Ulcerative colitis (UC) medications are drugs that ... Another class of drugs to treat UC is called biologics, but they are usually given to people with moderate-to-severe disease.

Vedolizumab biosimilar is under clinical development by Polpharma Biologics and currently in Phase III for Ulcerative Colitis. According to GlobalData, Phase III drugs for Ulcerative Colitis have a 60 ...

DB-001 is under clinical development by Direct Biologics and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase I drugs for Ulcerative Colitis have an 84% phase transition ...

However, biologics are less likely to raise a person ... Learn about keeping ulcerative colitis in remission. A 2021 review found that treatments for IBD did not increase the risks of COVID ...

2. Development of Janus Kinase (JAK) Inhibitors: Oral JAK inhibitors such as tofacitinib have been approved for the treatment of ulcerative colitis, offering an alternative to biologics for ...

An expert clinician expands on efficacy results seen in a study comparing intravenous and subcutaneous biologics.